TrialBlood2016

Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.

Maria Pia Cicalese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.